PFKFB4 downregulation impairs decidualization via disturbing the glycolysis and GSK3β/β-catenin pathway and contributes to preeclampsia
Cellular Signalling · 2026-10 · 146 · 112635
DOI: 10.1016/j.cellsig.2026.112635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026-10. Verfasst von Xiaohui Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Shandong Normal University, Jinan, Shandong 250014, China. Hauptthemen laut MEDLINE: Pre-Eclampsia, Phosphofructokinase-2, Glycogen Synthase Kinase 3 beta, beta Catenin. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Preeclampsia (PE), a pregnancy-specific complication threatening maternal and fetal health, has an elusive pathogenesis. While placental dysplasia is a core driver, decidualization is essential for placentation. Our prior RNA sequencing identified significant downregulation of the key glycolytic enzyme PFKFB4 in decidual tissue from severe PE (sPE) patients. Here, we confirmed markedly lower PFKFB4 expression in sPE decidual tissue than in normal pregnant (NP) women. In in vitro artificial decidualization models, PFKFB4 expression increased significantly with decidualization progression, and siRNA-mediated PFKFB4 knockdown strongly impaired this process. Reducing glucose consumption, lactate production, cell proliferation, and migration. Co-immunoprecipitation (Co-IP) experiments showed that PFKFB4 interacts with GSK3β; PFKFB4 knockdown inhibited the GSK3β/β-catenin pathway, which, on the one hand, further suppressed glycolysis by downregulating LDHA and inducing cellular energy depletion, and on the other hand, decreased the expression of proliferation-related genes, thereby inhibiting cell proliferation and migration at energy metabolism and gene expression levels, and ultimately leading to decidualization defects. In summary, PFKFB4 is a dual regulator of aerobic glycolysis and the GSK3β/β-catenin pathway in decidualization; its downregulation in sPE impairs decidualization, potentially reducing trophoblast invasion and triggering placental dysplasia, highlighting PFKFB4 as a potential PE biomarker and therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Shandong Normal University, Jinan, Shandong 250014, China.
- Department of Reproductive Medicine, Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200135, China.
- Department of Reproductive Medicine, Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200135, China. Electronic add…
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Li, X., Zeng, Y., Liu, Y., Xu, Y., & Zhang, C. (2026). PFKFB4 downregulation impairs decidualization via disturbing the glycolysis and GSK3β/β-catenin pathway and contributes to preeclampsia. Cellular Signalling, 146, 112635. https://doi.org/10.1016/j.cellsig.2026.112635
Vancouver
Li X, Zeng Y, Liu Y, Xu Y, Zhang C. PFKFB4 downregulation impairs decidualization via disturbing the glycolysis and GSK3β/β-catenin pathway and contributes to preeclampsia. Cellular Signalling. 2026;146:112635. doi:10.1016/j.cellsig.2026.112635
BibTeX
@article{Li2026,
author = {Li, Xiaohui and Zeng, Yan and Liu, Yutong and Xu, Yanxin and Zhang, Cong},
title = {PFKFB4 downregulation impairs decidualization via disturbing the glycolysis and GSK3β/β-catenin pathway and contributes to preeclampsia},
journal = {Cellular Signalling},
year = {2026},
volume = {146},
pages = {112635},
doi = {10.1016/j.cellsig.2026.112635}
}
EUVIMED